Skip to content
TrialScanner

NCT03802201

Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia

Phase 2CompletedPTGXLead

Registry record

Lead sponsor
Protagonist Therapeutics, Inc.
Conditions
β-thalassemia; Ineffective Erythropoiesis; Chronic Anemia
Primary completion
Jul 31, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03802201 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03802201: Study of PTG-300 in Non-Trans... | TrialScanner